ZA9710632B - New polymorphic form of doxazosin mesylate (form 1) - Google Patents

New polymorphic form of doxazosin mesylate (form 1)

Info

Publication number
ZA9710632B
ZA9710632B ZA9710632A ZA9710632A ZA9710632B ZA 9710632 B ZA9710632 B ZA 9710632B ZA 9710632 A ZA9710632 A ZA 9710632A ZA 9710632 A ZA9710632 A ZA 9710632A ZA 9710632 B ZA9710632 B ZA 9710632B
Authority
ZA
South Africa
Prior art keywords
doxazosin mesylate
new polymorphic
polymorphic form
new
doxazosin
Prior art date
Application number
ZA9710632A
Other languages
English (en)
Inventor
Grafe Ingomar Dr
Moersdorf Johann Peter Dr
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Publication of ZA9710632B publication Critical patent/ZA9710632B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9710632A 1996-12-20 1997-01-01 New polymorphic form of doxazosin mesylate (form 1) ZA9710632B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96120601A EP0849264A1 (de) 1996-12-20 1996-12-20 Neue polymorphe Form von doxazosinmesylat (Form I)

Publications (1)

Publication Number Publication Date
ZA9710632B true ZA9710632B (en) 1998-11-11

Family

ID=8223529

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710632A ZA9710632B (en) 1996-12-20 1997-01-01 New polymorphic form of doxazosin mesylate (form 1)

Country Status (10)

Country Link
US (1) US6130218A (ja)
EP (1) EP0849264A1 (ja)
JP (1) JPH10182639A (ja)
KR (1) KR19980064286A (ja)
CA (1) CA2224916A1 (ja)
HU (1) HUP9702480A3 (ja)
IL (1) IL122420A (ja)
NZ (1) NZ329404A (ja)
TW (1) TW420678B (ja)
ZA (1) ZA9710632B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19800214A1 (de) 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US6706721B1 (en) * 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
DE19912573A1 (de) * 1999-03-19 2000-09-21 Knoll Ag Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D
US7087613B2 (en) * 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA74803C2 (uk) * 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US8383627B2 (en) 2007-12-24 2013-02-26 Cipla Limited Crystalline polymorph of doxazosin mesylate (form IV) and process for preparation thereof
CN109988158A (zh) * 2018-01-03 2019-07-09 合肥立方制药股份有限公司 X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途
KR20190119416A (ko) 2018-04-12 2019-10-22 조선대학교산학협력단 다이빙 후드
CN111303130B (zh) * 2018-12-11 2021-09-14 合肥立方制药股份有限公司 一种多沙唑嗪甲磺酸盐晶型、其制备方法及用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4188390A (en) 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
EP0459666B1 (en) * 1990-05-31 1994-11-09 Pfizer Inc. Medicaments against impotence
WO1994009783A1 (en) * 1992-11-04 1994-05-11 Sepracor, Inc. Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition
US5412095A (en) * 1993-04-29 1995-05-02 Abbott Laboratories Terazosin monohydrochloride and processes and intermediate for its production
US5504207A (en) * 1994-10-18 1996-04-02 Abbott Laboratories Process and intermediate for the preparation of terazosin hydrochloride dihydrate

Also Published As

Publication number Publication date
IL122420A0 (en) 1998-06-15
AU4690497A (en) 1998-06-25
NZ329404A (en) 1999-02-25
TW420678B (en) 2001-02-01
AU720753B2 (en) 2000-06-08
EP0849264A1 (de) 1998-06-24
IL122420A (en) 2000-06-01
CA2224916A1 (en) 1998-06-20
HUP9702480A2 (hu) 1999-04-28
JPH10182639A (ja) 1998-07-07
HUP9702480A3 (en) 1999-06-28
US6130218A (en) 2000-10-10
HU9702480D0 (en) 1998-03-02
KR19980064286A (ko) 1998-10-07

Similar Documents

Publication Publication Date Title
PL330753A1 (en) Method of obtaining 2,3-dihalogenopropanols
ZA9710632B (en) New polymorphic form of doxazosin mesylate (form 1)
PL327733A1 (en) Method of obtaining polyethylene (2,6-naphtalate)
PL330400A1 (en) Method of obtaining azacyclohexapeptides
ZA9710633B (en) New polymorphic form of doxazosin mesylate (form ii)
PL331899A1 (en) Method of obtaining bis-indolyl malimides
PL328571A1 (en) Methods of obtaining biphenylisoxazol sulphonamides
IL135711A0 (en) Novel polymorphic forms of cipamfylline
PL332141A1 (en) Method of obtaining fluoxetin
HUP0100612A3 (en) Method of screening therapeutic agents
AU720753C (en) New polymorphic form of doxazosin mesylate (Form I)
PL320529A1 (en) Apparatus for combined drilling of blast-holes and anchor-holes
GB9619402D0 (en) Screening of enclosures
PL317181A1 (en) Method of obtaining novel alkanocarbonamides-derivatives of 4-sulphonamido-4'-aminobenzene
CA83885S (en) Set of screens
TW298062U (en) Improvement of slowly-descending escape apparatus
TW294983U (en) Structure of auto-adjustable drilling machine
TW399399U (en) Improved structure of leveling apparatus
TW300446U (en) Improved structure of back-patting apparatus
TW358610U (en) Improvement of inter-com
TW303899U (en) Improved fastening structure of template (1)
PL336473A1 (en) Method of obtaining 1,4,7,10-tetrazacyclodekane
TW315731U (en) Improved structure of fitness equipment
PL303603A1 (en) Method of obtaining 2,6-dimethyl-o-benzoquinone
PL330754A1 (en) Method of obtaining tetra-aza-macrotocycles